The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
We want to share a message of gratitude to research staff and community as we begin the new funding cycle for the HIV/AIDS clinical trials networks from Dr. Carl Dieffenbach, Director, Division of AIDS, NIAID.
The Office of HIV/AIDS Network Coordination (HANC) programs are referred to as areas of coordination. Within each area of coordination are numerous work groups that are integral to advancing the research goals and objectives defined by the HIV/AIDS Clinical Trials Networks and the Division of AIDS.
HANC supports a number of trans-institute behavioral science groups composed of experts that are working to advance research and clinical trials through cross-network collaboration.
HANC supports Community Partners, The Legacy Project, and the COVID-19 CAB coalition to achieve representation and build relationships with historically underrepresented communities in clinical research.
HANC supports cross-network working groups for network leadership, communications, data management centers, performance evaluation, and site coordinators to promote greater information sharing, collaboration, and process standardization.
HANC supports several cross-network laboratory working groups and committees with the aim of harmonizing processes and procedures, ensuring standard quality assurance for protocol-specified assays and laboratory preparedness for network clinical trials.
On behalf of the Office of HIV/AIDS Network Coordination and Community Partners, you are invited to participate in a webinar featuring the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. The IMPAACT Network Leadership will present their research priorities and goals for the next seven years and highlight how community will be engaged as part of their priorities. This is an opportunity for community to engage and ask questions.
Working together, we can be the generation to end the HIV/AIDS epidemic. Know the facts, spread the word, volunteer for a study, or join a community advisory board.